Cardiovascular pressor effects of orexins in the dorsomedial hypothalamus

Tzu Ling Li, Jennifer Y.S. Chen, Shang Cheng Huang, Yu Wen E. Dai, Ling Ling Hwang

研究成果: 雜誌貢獻文章

3 引文 (Scopus)

摘要

Orexins are important regulators of cardiovascular functions in various physiological and pathological conditions. The dorsomedial hypothalamus (DMH), an essential mediator of cardiovascular responses to stress, contains dense orexinergic innervations and receptors. We examined whether orexins can regulate cardiovascular functions through their actions in the DMH in anesthetized rats. An intra-DMH injection of orexin A (30 pmol) produced elevation of arterial pressure and heart rate. Orexin A-sensitive sites were located within or immediately adjacent to the DMH and larger responses were induced at the compact part of the dorsomedial hypothalamic nucleus. Orexin A-induced responses were attenuated by intra-DMH pretreatment with an orexin receptor 1 (OX1R) antagonist, SB-334867 (15 nmol) (17.7 ± 2.8 vs. 5.2 ± 1.0 mmHg; 54.6 ± 10.0 vs. 22.8 ± 7.4 beats/min). Intra-DMH applied [Ala11,D-Leu15]-orexin B (300 pmol), an orexin receptor 2 (OX2R) agonist, elicited cardiovascular responses mimicking the responses of orexin A, except for a smaller pressor response (7.4 ± 1.7 vs. 16.4 ± 1.8 mmHg). In a series of experiment, effects of orexin B (100 pmol) and then orexin A (30 pmol), were examined at a same site. Two patterns of responses were observed in 12 intra-DMH sites: (1) both orexin A and B (9 sites), and (2) only orexin A (3 sites) induced cardiovascular responses, respectively suggesting OX1 R/OX2R-mediated and OX1R-predominant mechanisms. In conclusion, orexins regulated cardiovascular functions through OX1R/OX2R- or OX1R-mediated mechanisms at different locations in the DMH.
原文英語
頁(從 - 到)343-350
頁數8
期刊European Journal of Pharmacology
818
DOIs
出版狀態已發佈 - 一月 5 2018

指紋

Hypothalamus
Orexin Receptors
Orexins
Dorsomedial Hypothalamic Nucleus
Arterial Pressure
Heart Rate
Injections

ASJC Scopus subject areas

  • Pharmacology

引用此文

Cardiovascular pressor effects of orexins in the dorsomedial hypothalamus. / Li, Tzu Ling; Chen, Jennifer Y.S.; Huang, Shang Cheng; Dai, Yu Wen E.; Hwang, Ling Ling.

於: European Journal of Pharmacology, 卷 818, 05.01.2018, p. 343-350.

研究成果: 雜誌貢獻文章

Li, Tzu Ling ; Chen, Jennifer Y.S. ; Huang, Shang Cheng ; Dai, Yu Wen E. ; Hwang, Ling Ling. / Cardiovascular pressor effects of orexins in the dorsomedial hypothalamus. 於: European Journal of Pharmacology. 2018 ; 卷 818. 頁 343-350.
@article{c4b37dfdc1164b3789f252c725e080dc,
title = "Cardiovascular pressor effects of orexins in the dorsomedial hypothalamus",
abstract = "Orexins are important regulators of cardiovascular functions in various physiological and pathological conditions. The dorsomedial hypothalamus (DMH), an essential mediator of cardiovascular responses to stress, contains dense orexinergic innervations and receptors. We examined whether orexins can regulate cardiovascular functions through their actions in the DMH in anesthetized rats. An intra-DMH injection of orexin A (30 pmol) produced elevation of arterial pressure and heart rate. Orexin A-sensitive sites were located within or immediately adjacent to the DMH and larger responses were induced at the compact part of the dorsomedial hypothalamic nucleus. Orexin A-induced responses were attenuated by intra-DMH pretreatment with an orexin receptor 1 (OX1R) antagonist, SB-334867 (15 nmol) (17.7 ± 2.8 vs. 5.2 ± 1.0 mmHg; 54.6 ± 10.0 vs. 22.8 ± 7.4 beats/min). Intra-DMH applied [Ala11,D-Leu15]-orexin B (300 pmol), an orexin receptor 2 (OX2R) agonist, elicited cardiovascular responses mimicking the responses of orexin A, except for a smaller pressor response (7.4 ± 1.7 vs. 16.4 ± 1.8 mmHg). In a series of experiment, effects of orexin B (100 pmol) and then orexin A (30 pmol), were examined at a same site. Two patterns of responses were observed in 12 intra-DMH sites: (1) both orexin A and B (9 sites), and (2) only orexin A (3 sites) induced cardiovascular responses, respectively suggesting OX1 R/OX2R-mediated and OX1R-predominant mechanisms. In conclusion, orexins regulated cardiovascular functions through OX1R/OX2R- or OX1R-mediated mechanisms at different locations in the DMH.",
keywords = "Blood pressure, Dorsomedial hypothalamus, Hypocretin, Orexin, SB334867, [Ala,D-Leu]-orexin B",
author = "Li, {Tzu Ling} and Chen, {Jennifer Y.S.} and Huang, {Shang Cheng} and Dai, {Yu Wen E.} and Hwang, {Ling Ling}",
year = "2018",
month = "1",
day = "5",
doi = "10.1016/j.ejphar.2017.11.004",
language = "English",
volume = "818",
pages = "343--350",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",

}

TY - JOUR

T1 - Cardiovascular pressor effects of orexins in the dorsomedial hypothalamus

AU - Li, Tzu Ling

AU - Chen, Jennifer Y.S.

AU - Huang, Shang Cheng

AU - Dai, Yu Wen E.

AU - Hwang, Ling Ling

PY - 2018/1/5

Y1 - 2018/1/5

N2 - Orexins are important regulators of cardiovascular functions in various physiological and pathological conditions. The dorsomedial hypothalamus (DMH), an essential mediator of cardiovascular responses to stress, contains dense orexinergic innervations and receptors. We examined whether orexins can regulate cardiovascular functions through their actions in the DMH in anesthetized rats. An intra-DMH injection of orexin A (30 pmol) produced elevation of arterial pressure and heart rate. Orexin A-sensitive sites were located within or immediately adjacent to the DMH and larger responses were induced at the compact part of the dorsomedial hypothalamic nucleus. Orexin A-induced responses were attenuated by intra-DMH pretreatment with an orexin receptor 1 (OX1R) antagonist, SB-334867 (15 nmol) (17.7 ± 2.8 vs. 5.2 ± 1.0 mmHg; 54.6 ± 10.0 vs. 22.8 ± 7.4 beats/min). Intra-DMH applied [Ala11,D-Leu15]-orexin B (300 pmol), an orexin receptor 2 (OX2R) agonist, elicited cardiovascular responses mimicking the responses of orexin A, except for a smaller pressor response (7.4 ± 1.7 vs. 16.4 ± 1.8 mmHg). In a series of experiment, effects of orexin B (100 pmol) and then orexin A (30 pmol), were examined at a same site. Two patterns of responses were observed in 12 intra-DMH sites: (1) both orexin A and B (9 sites), and (2) only orexin A (3 sites) induced cardiovascular responses, respectively suggesting OX1 R/OX2R-mediated and OX1R-predominant mechanisms. In conclusion, orexins regulated cardiovascular functions through OX1R/OX2R- or OX1R-mediated mechanisms at different locations in the DMH.

AB - Orexins are important regulators of cardiovascular functions in various physiological and pathological conditions. The dorsomedial hypothalamus (DMH), an essential mediator of cardiovascular responses to stress, contains dense orexinergic innervations and receptors. We examined whether orexins can regulate cardiovascular functions through their actions in the DMH in anesthetized rats. An intra-DMH injection of orexin A (30 pmol) produced elevation of arterial pressure and heart rate. Orexin A-sensitive sites were located within or immediately adjacent to the DMH and larger responses were induced at the compact part of the dorsomedial hypothalamic nucleus. Orexin A-induced responses were attenuated by intra-DMH pretreatment with an orexin receptor 1 (OX1R) antagonist, SB-334867 (15 nmol) (17.7 ± 2.8 vs. 5.2 ± 1.0 mmHg; 54.6 ± 10.0 vs. 22.8 ± 7.4 beats/min). Intra-DMH applied [Ala11,D-Leu15]-orexin B (300 pmol), an orexin receptor 2 (OX2R) agonist, elicited cardiovascular responses mimicking the responses of orexin A, except for a smaller pressor response (7.4 ± 1.7 vs. 16.4 ± 1.8 mmHg). In a series of experiment, effects of orexin B (100 pmol) and then orexin A (30 pmol), were examined at a same site. Two patterns of responses were observed in 12 intra-DMH sites: (1) both orexin A and B (9 sites), and (2) only orexin A (3 sites) induced cardiovascular responses, respectively suggesting OX1 R/OX2R-mediated and OX1R-predominant mechanisms. In conclusion, orexins regulated cardiovascular functions through OX1R/OX2R- or OX1R-mediated mechanisms at different locations in the DMH.

KW - Blood pressure

KW - Dorsomedial hypothalamus

KW - Hypocretin

KW - Orexin

KW - SB334867

KW - [Ala,D-Leu]-orexin B

UR - http://www.scopus.com/inward/record.url?scp=85032902293&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032902293&partnerID=8YFLogxK

U2 - 10.1016/j.ejphar.2017.11.004

DO - 10.1016/j.ejphar.2017.11.004

M3 - Article

AN - SCOPUS:85032902293

VL - 818

SP - 343

EP - 350

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

ER -